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ABSTRACT
Background: The World Health Organization recommends serum
ferritin concentrations as the best indicator of iron deficiency (ID).
Unfortunately, ferritin increases with infections; hence, the preva-
lence of ID is underestimated.
Objective: The objective was to estimate the increase in ferritin in
32 studies of apparently healthy persons by using 2 acute-phase
proteins (APPs), C-reactive protein (CRP) and a1-acid glycoprotein
(AGP), individually and in combination, and to calculate factors to
remove the influence of inflammation from ferritin concentrations.
Design: We estimated the increase in ferritin associated with in-
flammation (ie, CRP .5 mg/L and/or AGP .1 g/L). The 32 studies
comprised infants (5 studies), children (7 studies), men (4 studies),
and women (16 studies) (n = 8796 subjects). In 2-group analyses
(either CRP or AGP), we compared the ratios of log ferritin with or
without inflammation in 30 studies. In addition, in 22 studies, the
data allowed a comparison of ratios of log ferritin between 4 sub-
groups: reference (no elevated APP), incubation (elevated CRP
only), early convalescence (both APP and CRP elevated), and late
convalescence (elevated AGP only).
Results: In the 2-group analysis, inflammation increased ferritin by
49.6% (CRP) or 38.2% (AGP; both P , 0.001). Elevated AGP was
more common than CRP in young persons than in adults. In the
4-group analysis, ferritin was 30%, 90%, and 36% (all P , 0.001)
higher in the incubation, early convalescence, and late convales-
cence subgroups, respectively, with corresponding correction fac-
tors of 0.77, 0.53, and 0.75. Overall, inflammation increased ferritin
by ’30% and was associated with a 14% (CI: 7%, 21%) underes-
timation of ID.
Conclusions: Measures of both APP and CRP are needed to esti-
mate the full effect of inflammation and can be used to correct
ferritin concentrations. Few differences were observed between age
and sex subgroups. Am J Clin Nutr 2010;92:546–55.
INTRODUCTION
Plasma ferritin concentrations reflect the concentration of
stored iron in the liver (1), and most investigators accept that
serum ferritin concentrations,12 or,15 lg/L in those younger
than or older than 5 y, respectively, indicate iron deficiency (2,
3). In addition, plasma ferritin concentrations respond well in
iron-intervention studies (4) and were the principal recommen-
dation of the World Health Organization (WHO) at a meeting in
2004 to discuss the best way of assessing iron status in pop-
ulations (5). However, ferritin is also a positive acute-phase
protein (APP) that is elevated in the presence of infection or
inflammation (6, 7). Therefore, the WHO working group rec-
ommended that ferritin measurements should be accompanied
by the analysis of one or more APPs to detect the presence of
infection or inflammation (5, 8). However, there is uncertainty
about how APP should be used. Regression analyses of data
from African American infants and Guatemalan school-age
children showed that serum ferritin correlated with APP con-
centrations but found poor positive predictive values (9). In-
vestigators have suggested raising ferritin thresholds to higher
values in the presence of inflammation to discriminate iron
deficiency (3), but others have suggested that such action is
fraught with uncertainty (2). Likewise, the exclusion of results
from subjects with inflammation (8, 10) could bias the results if
iron-deficient persons are more prone to infection. It is also
impractical if the number of persons with elevated APP in
a study population is high, eg, as in The Gambia, where .90%
of apparently healthy infants had elevated APP concentrations
(11).
We believe that regression analysis is poorly predictive of
ferritin concentrations (9) because the increase in ferritin after
infection follows a different pattern than that of either C-re-
active protein (CRP) or a1-acid glycoprotein (AGP) (12). At the
onset of infection, CRP rises rapidly and reaches maximum
concentrations between 24 and 48 h, whereas AGP may take
4–5 d to reach a plateau (13). As the intensity of infection
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diminishes, CRP falls rapidly, whereas AGP remains elevated.
In contrast, ferritin rises rapidly within a few hours of a trauma
and remains elevated after the CRP concentrations have sub-
sided and while AGP concentrations are still increased (14).
Plasma retinol concentrations are also influenced by in-
flammation and to overcome the different decay times of the
inflammatory protein and to avoid excluding data, we devised
a way of using elevated APPs to categorize apparently healthy
subjects by their inflammatory state. This method also produced
correction factors to remove the influence of inflammation (15).
In this article we use the same method for plasma ferritin con-
centrations.
METHODS
Choice of studies
The studies were initially identified by using “ferritin”
and “inflammation” or “acute phase proteins” or “CRP”, “a1-
antichymotrypsin”(ACT) or “AGP” or “orosomucoid” as key
words to interrogate the PubMed database (http://www.ncbi.
nlm.nih.gov/pubmed/) with no time limit. ACT was included
because it has similar characteristics on infection to CRP (13,
16). Orosomucoid is an older and alternative name for AGP. Of
the initial studies identified, studies were eliminated if they did
not provide data for ferritin and at least 2 APP data in apparently
healthy human volunteers. An apparently healthy person was
defined as someone showing no outward signs of infection.
Thus, they could have parasites in their bodies or be HIV
positive but outwardly show no signs of infection.
Reference lists from suitable reports were cross-checked for
other studies. Our knowledge of persons who had measured
APP concentrations provided us with the names of persons who
had unpublished data, who agreed to let us use their data. We
initially identified 39 studies, Data from 8 of these studies were
no longer available, authors from 2 of the studies could not be
contacted, and one unpublished study was not released. The
remaining 28 studies were discussed at our first meeting, and it
was decided that the study populations in some could be
subdivided: eg, pregnant and nonpregnant, night blind and
non–night blind, or HIV-1 positive and HIV-1 negative. Men
and women in the same study were also examined separately,
and there were separate groups for infants and children. We did
not separate infants or children by sex because there was no
available information that sex-related factors influenced iron
stores until a girl reached menarche. For intervention studies,
only the baseline or first available data in any study were used.
This produced a list of 35 separate study groups, which were
analyzed before a second meeting, during which it was decided
to remove 3 of these studies [subjects with prostate-specific
antigen .2 units (17), unpublished data on Zairian adoles-
cents some of whom may have had clinical malaria and un-
published data from Papua New Guinea] because we knew too
little about the subjects and whether they could be described
as “apparently healthy.” The results described in this article
were obtained from the 32 study groups listed in Table 1. Note
that the references are given as the source of the data. The
information shown in this article may differ from those
sources because we included only subjects for whom ferritin
and 2 APP results were available.
Biochemical data
In all investigations, plasma or serum ferritin concentrations
were measured by using the manufacturers’ kits. The APPs were
measured by using radial immuno-diffusion (18), immuno-
turbidimetry (19, 20), and enzyme-linked immunosorbent assay
(21). We made no attempt to correct for differences between
methods because we found no discernable difference in ferritin
ratios (see Study methods below) computed for the different
assay methods (data not shown). Thresholds used to define
abnormal ferritin were ,12 or ,15 lg/L in those , and .5 y
of age, respectively (3). Inflammation was indicated when the
CRP concentration was .5 mg/L and/or the AGP concentration
was .1 g/L (15).
Statistical analysis
Data from Pakistan
In one study of Pakistani preschool children (19), ferritin, AGP,
and ACT data were available. As indicated above, ACT can
substitute for CRP (13, 16), and inflammation was indicated when
the ACT concentration was .0.6 g/L. Both CRP and ACT rise
rapidly on stimulation and plateau within 24–48 h. Thus, ACT
can identify the incubation group as accurately as can CRP, and
ACT is reasonably good at differentiating the convalescent groups
as well. The analyses were run with and without Pakistan (data
not shown), and the results were qualitatively the same; therefore,
Pakistan was included in both the 2- and 4-group analyses.
Study methods
We compared serum ferritin concentrations between subsets of
individuals. We used natural logs of these concentrations because
distributions of serum ferritin were frequently skewed. We
converted the results back to the original scales to facilitate
interpretation; thus, the CIs were not necessarily symmetrically
distributed around the overall summary estimate. The choice of
the natural log transformation enabled the geometric means to be
calculated as a summary; the back-transformed difference in the
means of the logs was the ratio of the geometric means of the
original data. In the tables, the differences in ferritin between
groups are expressed as ratios.
Data analysis
To assess the relation between the individual APPs and serum
ferritin, we first conducted a 2-group meta-analysis (15) for CRP
and AGP separately. Individuals were classified as having a normal
CRP if the serum concentration was 5 mg/L and as having
a high concentration if it was .5 mg/L. Similarly, we used
a cutoff of 1.0 g/L for AGP. APP concentrations recorded as being
below the lowest detectable level or higher than the limit of de-
tection were classified as normal and high, respectively. We cal-
culated the mean log ferritin value of each group and the study
summary, which was the difference between the mean log ferritin
concentration for the normal group and that for the high group.
The 2-group analysis was done on all possible studies and sepa-
rately on the groups containing the infants, children, men, and
women because of the potentially large differences in plasma
ferritin concentrations between these subgroups.
In the 4-group analysis, we classified individuals from each
study as reference, incubating, early convalescence, or late
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convalescence on the basis of the values for 2 APPs. In the case of
Pakistan, ACTwas substituted for CRP, and the analyses were run
with and without this group, as described above. Individuals in
the reference group were defined as having normal APPs, ie, both
were less than or equal to their respective cutoff values. The
incubation group was defined by a normal AGP and an elevated
CRP value. The early convalescence group was defined by el-
evated AGP and CRP concentrations, and the late convalescence
group by an elevated AGP and a normal CRP concentration. The
4-group analysis resulted in a comparison of 6 pairs of mean log
ferritin concentrations. Each of these was summarized by study
and then analyzed as described previously.
Within-study variance
The summary statistic (effect size) was the difference between 2
means, and the variability associated with each summary statistic
was related to sample sizes. In general, studies with a large number
of samples will have smaller variability thanwill thosewith a small
number. To combine the summary statistics of all the studies,
traditional weights were calculated based on the inverse of the
within-study variance. In this way, studies with a large variance,
and therefore a relatively imprecise estimate of the study summary,
received less weight than a study with a smaller variance. Two
additional weighting methods were also examined: weights gen-
erated that were inversely proportional to sample sizes and the
sameweight for each study (data not shown). In general, the overall
summary statistic had the smallest variability when the inverse of
the within-study variance-weighting scheme was used.
In the 4-group analysis, to avoid the difficulty of interpretation
that would occur if different weights were computed for the
comparison of each pair, weights were computed from the sum of
the variances for the 4 groups and on the total sample size for the
4 groups. Although 6 comparisons were possible, only 3 had
practical use for interpretation of plasma ferritin concentrations
in cross-sectional studies, namely the comparison against the
reference group. To estimate the variability of the overall sum-
mary statistic and to provide study to study variation, the random-
effects model was used for all the analyses reported because it
allowed for small differences between studies and enabled the
generation of valid SDs.
RESULTS
Of the 32 study groups, 5 consisted of infants, 7 consisted of
preschool or school children, 4 consisted of men, and 16 con-
sisted of women (Table 1), which totaled 8796 subjects. Median
ferritin concentrations ranged widely from 6 to 489 lg/L, al-
though, in most studies (n = 28), the median was ,100 lg/L.
The prevalence of low ferritin concentrations similarly ranged
widely from 0% to 85%. Median CRP concentrations were
generally ,5 mg/L, except for subjects known to be HIV-
positive or exposed to malaria. Likewise, the median AGP
concentration was ,1 g/L, except in 5 groups: 2 of which were
HIV-positive, 1 of which was nonpregnant Zairian women, and 2
of which were preschool children.
The numbers and proportions of subjects by inflammation
group are shown in Table 2. The data are shown with and
without subjects from Pakistan, where there was a high pro-
portion of subjects with high AGP concentrations. The exclusion
of subjects from Pakistan, however, still showed that the largest
inflammation groups were those in late convalescence with high
AGP concentrations, but this was predominantly due to results
from studies in infants and children. In adult women, the highest
proportion of those with inflammation was found in the in-
cubation phase, and there was no appreciable difference between
phases for the men.
For the 2-group analysis in which either CRP (n = 8745) or
AGP (n = 8619) were examined separately, data from 30 study
groups were used in both cases to determine the relative dif-
ference in mean ferritin concentrations in those with and without
the respective elevated APP (Table 3). The 2 studies were ex-
cluded because there were no high CRP or AGP results, re-
spectively. The analyses produced geometric mean ferritin
concentrations that were 50% (P, 0.001) and 38% (P, 0.002)
higher when CRP and AGP were elevated by inflammation,
respectively (Table 3). To remove the influence of inflammation
from ferritin, these differences convert to multipliers of 0.67 and
0.73 to reduce concentrations of ferritin when CRP and AGP are
elevated, respectively. When different age and sex subgroups of
the studies were examined separately; the increase in ferritin
associated with an elevated CRP was similar in women (48%),
children (59%), and infants (64%, all P , 0.001) but not in the
men (17%; P = 0.676). For AGP, the increases in ferritin in the
subgroups were 33% for women, 39% for men, 28% for chil-
dren, and 73% for infants; however, these increases were only
significant in infants (P , 0.001).
For the 4-group analysis in which ferritin in the reference
group was compared with each of the other 3 inflammation
groups, 22 studies (7848 subjects) provided complete in-
formation (Table 1). Generally speaking, study groups that were
TABLE 2
Summaries of subject numbers in all studies and inflammation groups with and without Pakistan1
Groups All subjects
Acute-phase protein status
Incubation Early convalescence Late convalescence Reference
n n (%)
All studies 8796 526 (6) 810 (9) 2157 (25) 5303 (60)
All studies, without Pakistan 4250 521 (9) 506 (8) 754 (13) 4250 (70)
Infants 1278 49 (4) 121 (9) 226 (18) 882 (69)
Children 4151 34 (1) 428 (10) 1662 (40) 2027 (49)
Children, without Pakistan 1386 29 (2) 124 (9) 259 (19) 974 (70)
Men 281 35 (13) 53 (19) 43 (15) 150 (53)
Women 3086 408 (13) 208 (7) 226 (7) 2244 (73)
1 Grouping of subjects by acute-phase proteins is described in Table 1.
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excluded from the 4-group analysis had small sample sizes. The
numbers of studies of infants, children, men, and women for the
4-group analysis were 5, 3, 3, and 11 respectively. Two studies
were from areas where there was active transmission of malaria
(studies 23 and 25; Table 1), and 2 were from studies with
subjects previously infected with malaria (studies 1 and 8); 3 of
these remained in the 4-group analysis. Three groups were HIV-1
positive (studies 1, 10, and 18; 2 female, one male), and these also
remained in the 4-group analysis. Of the female groups, 4 were of
pregnant women and 2 remained in the 4-group analysis. There
was a very large range in the sizes of the different studies, which
remained even for the 4-group analysis.
In the 4-group analysis, there were significantly higher geo-
metric mean ferritin concentrations in the incubation (30%), early
convalescence (90%), and late convalescence (36%) groups than
in the reference group (all P , 0.001) (Table 4). These values
converted to correction multipliers of 0.77, 0.53, and 0.75, re-
spectively, to correct for serum ferritin values in the specific
groups for inflammation. The same pattern of differences was
also present in 3 of the subgroups, namely infants, children, and
women, for whom ferritin concentrations were 13–56%, 72–
155%, and 17–53% higher than those in the reference groups for
the incubation, early convalescence, and late convalescence
groups, respectively; for men, the respective values were 7%,
17%, and 61%. For infants, women, and children, ferritin was
significantly higher in 7 of 9 of the subgroups comparisons (P ,
0.05), whereas none of the differences were significant for men.
We also carried out comparisons of the ratios obtained from the
4-group analysis for different subgroups (Table 5), including
men, women, children, infants, all adults, pregnant and non-
pregnant women, HIV-positive and HIV-negative adults, persons
exposed and not exposed to malaria, and groups with high and
low ferritin concentrations. No significant difference emerged
for any subgroup or inflammatory group comparison.
Finally we determined the effects of correcting ferritin con-
centrations on the prevalence of iron deficiency in the 22 studies
used for the 4 group meta-analysis (Table 6). For each of the
studies in the 4-group meta-analysis, we calculated the ratio of
the prevalence of ferritin deficiency for all subjects divided by
that of the reference group. We then calculated the bias by
calculating the mean and the 5% and 95% CIs for this ratio (data
not shown) and finally subtracted those values from 100 to de-
termine the underestimation in prevalence of ferritin deficiency
before correction. The data were then corrected by using the
relevant correction factors (0.77, 0.53 and 0.75 as multipliers
corresponding to values elevated by 30%, 90%, and 36%, re-
spectively), and the calculation was repeated to determine the
prevalence of ID (ferritin deficiency) after correction. We also
performed similar calculations on serum ferritin concentrations
before and after correction to determine the percentage over-
estimate of serum ferritin for all study groups in uncorrected
data by comparison with the reference groups. We showed that,
without correction for inflammation, the prevalence of ID using
ferritin alone would be underestimated by 14% (CI: 7%, 21%)
and that the underestimate was brought about by the fact that
ferritin concentrations were 30% (CI: 15%, 45%) higher (Table
6). Correcting the data for inflammation by using both APPs
removed the deviations; however, if only one APP was used,
then ’50% of the underestimate of ID still remained because
only half of the ferritin increase was removed.
DISCUSSION
In the nutritional studies collected for these analyses, data were
obtained from persons who were apparently healthy but in whom
a subsequent analysis showed some covert inflammation. Most
TABLE 4
Ferritin ratios for respective inflammation versus reference group
comparisons: 4-group meta-analysis1
Studies compared Ratio (95% CI) P
Incubation vs reference
All studies 1.30 (1.15, 1.47) ,0.001
Infants 1.13 (0.90, 1.41) 0.30
Children 1.56 (1.22, 1.99) ,0.001
Men 1.07 (0.79, 1.44) 0.66
Women 1.37 (1.07, 1.76) 0.01
Early convalescence vs reference
All studies 1.90 (1.51, 2.37) ,0.001
Infants 2.09 (1.66, 2.63) ,0.001
Children 2.55 (1.37, 4.72) 0.003
Men 1.17 (0.52, 2.65) 0.706
Women 1.72 (1.27, 2.33) ,0.001
Late convalescence vs reference
All studies 1.36 (1.19, 1.55) ,0.001
Infants 1.42 (1.14, 1.76) ,0.002
Children 1.53 (1.15, 2.04) ,0.004
Men 1.61 (0.98, 2.64) 0.058
Women 1.17 (0.96, 1.43) 0.124
1 Values are ratios of geometric mean ferritin concentrations for the
respective pairs from the 4-group analysis. There were 6 possible group
comparisons, but only the 3 most important ones are shown. For the group
comparisons, there were a total of 22 studies (n = 7848): 5 in infants (n =
1278), 3 in children (n = 3695), 3 in men (n = 251), and 11 in women (n =
2624).
TABLE 3
Ferritin ratios for subjects with or without inflammation as indicated by
C-reactive protein (CRP ) or a1-acid glycoprotein (AGP) concentration:
2-group analysis1
No. of
studies
No. of
participants Ratio (95% CI) P
CRP
All studies 302 8745 1.50 (1.34, 1.67) ,0.001
Infants 5 1278 1.64 (1.33, 2.03) ,0.001
Children 7 4151 1.59 (1.23, 2.06) ,0.001
Men 3 251 1.17 (0.56, 2.41) 0.676
Women 15 3065 1.48 (1.31, 1.68) ,0.001
AGP
All studies 303 8619 1.38 (1.13, 1.68) ,0.002
Infants 5 1278 1.73 (1.43, 2.09) ,0.001
Children 7 4151 1.28 (0.94, 1.74) 0.124
Men 4 281 1.39 (0.82, 2.37) 0.218
Women 14 2909 1.33 (0.98, 1.81) 0.071
1 Values are ratios of geometric mean ferritin concentrations for the
respective subgroups with and without inflammation from the 2-group
analysis.
2 Studies 3 and 21 were excluded because there were no high CRP
concentrations.
3 Studies 8 and 24 were excluded because there were no high AGP
concentrations.
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persons fell into the reference group category (ie, no elevated
inflammatory proteins (Table 2). In the reference group, nutri-
tional biomarkers will be least likely to be influenced by in-
flammation and ferritin values will be more likely to represent the
true nutritional status of the specific population groups.
In the groups with inflammation, most infants and children
were in late convalescence and the fewest were in the incubation
group. The latter is not surprising because the incubation period is
at most 48 h (13), so the intensity of infection would have to be
very high for numbers in this group to be large. In contrast, the
late convalescent group may represent a much longer period if
nutritional status is poor and recovery from disease is slow. In
adult women, however, the situation was reversed, which sug-
gested that convalescence was shorter than in infants and chil-
dren, probably because humeral immunity was more fully
developed and recovery quicker.
We analyzed 22 studies in which the reference and all 3 in-
flammation groups were present in infants, children, men, and
TABLE 5
Comparison of 4-group meta-analysis results between subgroups of different ages, sexes, and other characteristics
Reference versus
First subgroup Second subgroup
No. of studies No. of subjects Ratio (CI)1 No. of studies No. of subjects Ratio (CI) z P2
Men Women
Incubation 3 251 1.07 (0.79, 1.44) 11 2624 1.37 (1.07, 1.76) 21.24 0.21
Early convalescence 1.17 (0.52, 2.65) 1.72 (1.27, 2.33) 20.87 0.38
Late convalescence 1.61 (0.98, 2.64) 1.17 (0.96, 1.43) 1.18 0.24
Infants Children
Incubation 5 1278 1.13 (0.90, 1.41) 3 3695 1.56 (1.14, 1.76) 21.92 0.055
Early convalescence 2.09 (1.66, 2.63) 2.55 (1.14, 1.76) 20.58 0.56
Late convalescence 1.42 (1.14, 1.76) 1.53 (1.15, 2.04) 20.41 0.68
Infants Adults
Incubation 5 1278 1.13 (0.90, 1.41) 14 2875 1.29 (1.07, 1.57) 20.93 0.35
Early convalescence 2.09 (1.66, 2.63) 1.58 (1.16, 2.14) 1.45 0.15
Late convalescence 1.42 (1.14, 1.76) 1.26 (1.03, 1.55) 0.76 0.44
Children Adults
Incubation 3 3695 1.56 (1.22, 1.99) 14 2875 1.29 (1.07, 1.57) 1.18 0.24
Early convalescence 2.55 (1.37, 4.72) 1.58 (1.16, 2.14) 1.36 0.17
Late convalescence 1.53 (1.15, 2.04) 1.26 (1.03, 1.55) 1.07 0.29
Pregnant Nonpregnant
Incubation 5 1240 1.27 (0.98, 1.65) 6 1384 1.39 (1.00, 1.94) 20.42 0.68
Early convalescence 1.48 (0.83, 2.66) 1.78 (1.25, 2.54) 20.53 0.60
Late convalescence 1.29 (0.82, 2.03) 1.15 (0.83, 1.58) 0.41 0.68
Malaria exposure No malaria
Incubation 3 661 1.02 (0.76, 1.36) 19 7187 1.35 (1.19, 1.54) 21.73 0.08
Early convalescence 1.76 (1.20, 2.59) 1.92 (1.48, 2.48) 20.35 0.73
Late convalescence 1.67 (1.34, 2.08) 1.31 (1.13, 1.52) 1.78 0.08
HIV+ HIV2
Incubation 3 232 1.39 (0.96, 2.02) 19 7616 1.29 (1.12, 1.49) 0.36 0.72
Early convalescence 2.61 (1.29, 5.27) 1.83 (1.45, 2.32) 0.93 0.35
Late convalescence 1.76 (0.88, 3.51) 1.32 (1.17, 1.50) 0.81 0.42
Low ferritin3 High ferritin
Incubation 11 5777 1.41 (1.09, 1.83) 11 2071 1.25 (1.08, 1.44) 0.80 0.43
Early convalescence 1.83 (1.46, 2.30) 1.93 (1.35, 2.75) 20.24 0.81
Late convalescence 1.18 (1.01, 1.38) 1.46 (1.19, 1.80) 21.63 0.10
1 Values are ratios of the geometric mean ferritin concentrations (5% CI, 95% CI) for the respective pairs (reference vs inflammatory group) from the
4-group analysis for the specific subject groups.
2 P values reflect differences between ratios for respective inflammation and subgroup comparisons.
3 Studies were arbitrarily allocated to 2 groups on the basis of lower or higher mean ferritin concentrations (see Table 1).
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women, and we quantified the mean rise in ferritin concentrations
in the incubation period (at the start of an infection but before the
appearance of clinical symptoms, 30%), during early convales-
cence (the period immediately after clinical signs had dis-
appeared, 90%), and during late convalescence (36%). These
measurements were made on studies of apparently healthy
persons but in whom there was only evidence of covert in-
flammation as indicated by slightly elevated CRP and/or AGP
concentrations. The data clearly show that ferritin was increased
by inflammation, and the increased ferritin concentration in the
incubation group confirmed the report (14) that ferritin con-
centrations increased rapidly at the onset of inflammation.
There are often large differences in ferritin concentrations
between groups with different ages and sexes. We therefore
compared the increases in ferritin in the 3 inflammation sub-
groups in the different age and sex study groups to determine
whether the increases in ferritin were influenced by high or low
ferritin concentrations or by age, sex, pregnancy, HIV status, or
exposure to malaria. None of these factors significantly influ-
enced the increase in ferritin associated with the inflammatory
states. Essentially, this means that at each stage in the infection
cycle the increases in ferritin associated with inflammation were
proportional to ferritin concentrations of the group, where there
was no inflammation; ie, the reference group. This supports
earlier observations that the increase in ferritin produced by
inflammation was proportional to baseline concentrations (7).
The one group of studies in which therewas least conformity in
the effects of inflammation on ferritin was that in the men, in
whom there was little increase in ferritin in both the incubation
and early convalescence groups (Table 4). Studies 1, 2, and 6
(Table 1) contained the men who were included in the meta-
analysis. Mean ferritin concentrations were highest in these
groups, and ferritin concentrations in most individual men were
.100 lg/L (data not shown). It is possible that, when baseline
ferritin concentrations were very high, the inflammatory stimu-
lus on ferritin was not as great as in persons with lower con-
centrations. Mean ferritin concentrations in all of the women
groups in the meta-analysis were ,100 lg/L. Thus, although
there was no statistically significant difference in ferritin in-
creases when men were compared with women or when those
with high ferritin were compared with low ferritin, more studies
are needed of men with ferritin concentrations in the same range
as those of women to resolve this issue.
Two studies have recently reported that AGP was especially
useful at interpreting ferritin concentrations and at assessing iron
deficiency in HIV-infected Zimbabwean women (38) and Zanzi-
barian children prone to chronic malaria (39). We examined the
results in Table 5 to determine whether the ferritin ratios in the
convalescence groups of subjects exposed tomalaria (studies 1, 23,
and 25) or HIV positive (studies 2, 10, and 18; Table 1) were
different from those studies not similarly affected. There was some
evidence in the late convalescence subgroups of higher ferritin
ratios in the malaria-exposed subjects (ratio: 1.67; P = 0.08), but,
although there was a similar ferritin ratio in HIV-positive subjects
(1.76), the latter was not different from ferritin ratios of the HIV-
negative subjects in late convalescence (P = 0.81). Higher ratios
in late convalescence might suggest that the relation between
AGP and ferritin was particularly strong and possibly more useful
than CRP to correct the influence of inflammation on plasma
ferritin concentrations in persons with malaria (39). However, our
2-group meta-analyses of ferritin concentrations suggested that
the increase in ferritin was greater when CRP (50%) rather than
AGP (38%) was increased; therefore, we recommend strongly
against the use of one APP and suggest that both CRP and AGP
be used because they cover the full inflammation cycle and thus
will result in unbiased estimates of prevalence.
TABLE 6
Effect of correcting plasma ferritin concentrations on the prevalence of iron deficiency and plasma ferritin concentrations in the 22 studies in the 4-group
meta-analysis1
Prevalence of iron deficiency2 Serum ferritin concentration3
Group No. of studies Before correction After correction4 No. of studies Before correction After correction4
% underestimate % underestimate % overestimate % overestimate
All groups 19 14 (7, 21) 0 (210, 9) 22 30 (15, 45) 5 (23, 12)
Subgroups
Infants 5 16 (2, 31) 5 (214, 23) 5 26 (29, 61) 5 (217, 27)
Children 3 10 (26, 27) 22 (214, 10) 3 16 (2, 30) 22 (221, 17)
Men 1 —5 —5 3 37 (291, 165) 2 (247, 51)
Women 10 165 (4, 28) 45 (26, 13) 11 34 (7, 60) 7 (26, 21)
All groups 19
AGP only 14 (7, 21) 9 (2, 16) 22 30 (15, 45) 14 (3, 26)
CRP only 19 14 (7, 21) 5 (23, 13) 22 30 (15, 45) 13 (5, 22)
CRP only without Pakistan 18 14 (7, 22) 5 (23, 14) 21 31 (15, 47) 14 (4, 23)
1 Values are means (5% CI, 95% CI) before and after correction for inflammation. AGP, a1-acid glycoprotein; CRP, C-reactive protein.
2 Iron deficiency defined as ferritin concentrations ,12 lg/L for individuals 5 y of age (studies 12, 13, 16, 20, 25, 27, and 30) and ,15 lg/L for
individuals .5 y of age for all subjects compared with those in the reference groups and expressed as % underestimated of the number in the reference group.
3 The higher concentrations of ferritin for each study are expressed as a percentage of that in the reference groups minus 100 for the 22 studies.
4 Data were corrected by using both acute-phase proteins (AGP and CRP) to classify individuals into incubation, early, or late convalescence groups, and
ferritin concentrations were multiplied by 0.77, 0.53, or 0.75, respectively. When data were corrected for only 1 of the 2 acute-phase proteins, the multipliers
were 0.65 (CRP) or 0.72 (AGP) to correct the ferritin concentrations for the effects of inflammation.
5 Two studies for men and one study for women could not be included in these calculations because there was no iron deficiency in the reference
subgroup.
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The importance of using both APPs to correct a plasma ferritin
concentration was also shown when we applied the correction
factors to the data used in the meta-analysis to calculate the
percentage deficit in cases of ID when compared with the per-
centage of cases in the reference groups. With the use of both
APPs, there was an overall 14% underestimate in the prevalence
of ID based on low ferritin concentration, which can be compared
with the uncorrected prevalences of ID shown in Table 1. After
correction with the use of both APPs, the mean underestimatewas
reduced to zero; however, if either AGP or CRP was used alone,
an average prevalence of ID of 5% or 9%, respectively, remained
(Table 6). Likewise, we showed that, on average, ferritin con-
centrations were 30% higher in all subjects than in the respective
reference groups. However, when the overestimate was corrected
for only one or the other of the 2 APPs, half the overestimate still
remained. Obviously, these percentage values are averages from
the studies in this meta-analysis, and the actual numbers will
depend on the actual amount of inflammation in a specific study
population. The values do, however, give us a measure of the
effect of covert inflammation associated with both APP on serum
ferritin and indicate that it is important to remove the effect of
inflammation to correctly assess iron status on the basis of serum
ferritin concentrations.
It is possible that the underestimate in ID is .14%. Our value
is based on the difference in ferritin between all subjects and
those in the reference groups. Subjects in the inflammation
groups may have been deprived of iron during their illness and
be more iron deficient than those in the reference group. How-
ever, this is speculation and we can only use the ferritin data that
are available. The important thing is that the ferritin data are
corrected for inflammation to expose a more accurate mea-
surement of ID. This will be particularly important in in-
tervention studies in which inflammation may differ between
baseline and after intervention, both in the individuals and the
numbers affected. For reasons of cost and practicality, plasma
ferritin concentrations are the best biomarker of iron status (3,
5), and the WHO recommended ferritin for the purposes of
describing the prevalence of ID in a population with a single
number, except when inflammation was present (8). Correcting
serum ferritin concentrations for inflammation enables the dis-
tinct international standards of the WHO to be used and will
improve our ability to monitor the benefits of iron intervention
to reduce the global prevalence of anemia.
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